Adolescent substance abuse. Confidentiality and consent

Area of Science:

• Medical Law
• Adolescent Health
• Substance Abuse Treatment

Background:

• State laws permit minors to consent to substance abuse treatment, but significant state-to-state variability exists.
• Healthcare providers frequently encounter situations requiring assessment of adolescent competence for consent and decisions regarding parental notification.
• Maintaining patient confidentiality is crucial, with clear communication about its limitations.

Purpose of the Study:

• To highlight the legal landscape surrounding adolescent consent and confidentiality in substance abuse treatment.
• To inform healthcare providers about state-specific laws and best practices.
• To address challenges in managing confidentiality across various clinical and administrative processes.

Main Methods:

• Review of state laws regarding minor consent for substance abuse treatment.
• Analysis of ethical considerations for healthcare providers in adolescent care.
• Examination of confidentiality issues in drug testing, billing, and medical records.

Main Results:

• Adolescents possess consent capacity for alcohol and drug treatment in most states.
• Parental involvement is generally considered optimal, even when adolescents can consent independently.
• Confidentiality management requires careful attention to legal statutes and potential regulatory changes.

Conclusions:

• Healthcare providers must be cognizant of state-specific laws governing adolescent consent and confidentiality.
• Effective management of adolescent substance abuse treatment necessitates balancing patient autonomy with potential family involvement.
• Advocacy for robust consent and confidentiality statutes is essential for optimal adolescent healthcare outcomes.